Javascript must be enabled to continue!
Genome-wide analysis reveals prognostic value of novel signature CLU for malignant meningioma patients based on large-scale cohorts
View through CrossRef
Background: Meningioma is one of the most common tumors of central
nervous system. Although genetic alterations have been linked to
elevated risk of malignancy for meningioma patients, the incongruence
between clinical outcomes and WHO grade classification still exist.
Therefore, large-scale genome-wide expression profiles identifying
reliable biomarkers remains incompletely investigated. Methods: In order
to identify genes related to invasion and metastasis process in
meningiomas, genome-wide profiles in 145 meningioma patients were
identified using microarray datasets GSE12530, GSE16581 and GSE43290
from the Gene Expression Synthesis (GEO) database based on differential
tissues expression. Protein-protein interaction (PPI) network were
constructed and functional annotations of DEGs were evaluated using R
software. In addition, differential expression and prognostic value of
CLU on meningioma was evaluated using immunohistochemistry in WHO grade
II-III meningioma from AHYMUN, a real-world cohort. Results: A total of
58 DEGs were significantly associated with malignant behaviours of
meningioma. Next, CLU were identified as hub gene in the PPI network,
showing markedly prognostic implications in 67 meningioma patients.
Expression level of CLU significantly climbed with elevated WHO risk
classification. Interestingly, 40 genes were screened according to
differential CLU expression. Additionally, significant high expression
level of CLU were found in meningiomas tissue than normal tissues,
predicting significant poor prognosis for 100 meningiomas patients from
AHYMUN cohort. Conclusion: In conclusion, this study first reveals novel
role of CLU using genome-wide expression profiles in high-risk WHO grade
of meningioma and significant prognostic value based on large-scale
cohorts. This work laid the foundation for the targeted molecular
therapies and provided new insights into the treatment and prognostic
srategies of meningiomas.
Title: Genome-wide analysis reveals prognostic value of novel signature CLU for malignant meningioma patients based on large-scale cohorts
Description:
Background: Meningioma is one of the most common tumors of central
nervous system.
Although genetic alterations have been linked to
elevated risk of malignancy for meningioma patients, the incongruence
between clinical outcomes and WHO grade classification still exist.
Therefore, large-scale genome-wide expression profiles identifying
reliable biomarkers remains incompletely investigated.
Methods: In order
to identify genes related to invasion and metastasis process in
meningiomas, genome-wide profiles in 145 meningioma patients were
identified using microarray datasets GSE12530, GSE16581 and GSE43290
from the Gene Expression Synthesis (GEO) database based on differential
tissues expression.
Protein-protein interaction (PPI) network were
constructed and functional annotations of DEGs were evaluated using R
software.
In addition, differential expression and prognostic value of
CLU on meningioma was evaluated using immunohistochemistry in WHO grade
II-III meningioma from AHYMUN, a real-world cohort.
Results: A total of
58 DEGs were significantly associated with malignant behaviours of
meningioma.
Next, CLU were identified as hub gene in the PPI network,
showing markedly prognostic implications in 67 meningioma patients.
Expression level of CLU significantly climbed with elevated WHO risk
classification.
Interestingly, 40 genes were screened according to
differential CLU expression.
Additionally, significant high expression
level of CLU were found in meningiomas tissue than normal tissues,
predicting significant poor prognosis for 100 meningiomas patients from
AHYMUN cohort.
Conclusion: In conclusion, this study first reveals novel
role of CLU using genome-wide expression profiles in high-risk WHO grade
of meningioma and significant prognostic value based on large-scale
cohorts.
This work laid the foundation for the targeted molecular
therapies and provided new insights into the treatment and prognostic
srategies of meningiomas.
Related Results
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Abstract
Introduction
Due to indeterminate cytology, Bethesda III is the most controversial category within the Bethesda System for Reporting Thyroid Cytopathology. This study exam...
Increased life expectancy of heart failure patients in a rural center by a multidisciplinary program
Increased life expectancy of heart failure patients in a rural center by a multidisciplinary program
Abstract
Funding Acknowledgements
Type of funding sources: None.
INTRODUCTION Patients with heart failure (HF)...
Teores foliares de macronutrientes em crisântemos cultivados em substratos contendo composto de lixo urbano e casca de arroz carbonizada.
Teores foliares de macronutrientes em crisântemos cultivados em substratos contendo composto de lixo urbano e casca de arroz carbonizada.
O objetivo deste trabalho foi investigar a influência da adição de composto de lixo urbano (CLU) e de casca de arroz carbonizada (CAC) no crescimento e nos teores foliares de macro...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Whole Exome Sequencing of Meningioma in Sudanese Patients
Whole Exome Sequencing of Meningioma in Sudanese Patients
Introduction Meningioma is the second most common primary intracranial tumor of the central nervous system. in Sudan, meningioma is the most common primary brain tumor, among Sudan...
The effect of Clusterin level as a potential marker in women with polycystic ovary syndrome
The effect of Clusterin level as a potential marker in women with polycystic ovary syndrome
An organ with high metabolic activity, adipose tissue secretes a variety of adipocytokines that control the metabolism of fats and carbohydrates and advance insulin resistance (IR)...
Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis
Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis
Meningioma is the most common primary brain tumor and many studies have evaluated numerous biomarkers for their prognostic value, often with inconsistent results. Currently, no rel...
Link of BIN1, CLU, and fIDE Gene Polymorphisms with the Susceptibility
of Alzheimer’s Disease: Evidence from a Meta-analysis
Link of BIN1, CLU, and fIDE Gene Polymorphisms with the Susceptibility
of Alzheimer’s Disease: Evidence from a Meta-analysis
Background:
Alzheimer’s disease (AD) is the most common form of neurodegenerative disorder.
The association of BIN1, CLU, and IDE genetic polymorphisms with AD risk have been evalu...

